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Abstract
Shiga toxins (Stx) are the main virulence factors in enterohemorrhagic Escherichia coli (EHEC) infections, causing diarrhea
and hemolytic uremic syndrome (HUS). The genes encoding for Shiga toxin-2 (Stx2) are located in a bacteriophage. The
toxin is formed by a single A subunit and five B subunits, each of which has its own promoter sequence. We have previously
reported the expression of the B subunit within the eukaryotic environment, probably driven by their own promoter. The
aim of this work was to evaluate the ability of the eukaryotic machinery to recognize stx2 sequences as eukaryotic-like
promoters. Vero cells were transfected with a plasmid encoding Stx2 under its own promoter. The cytotoxic effect on these
cells was similar to that observed upon incubation with purified Stx2. In addition, we showed that Stx2 expression in Stx2-
insensitive BHK eukaryotic cells induced drastic morphological and cytoskeletal changes. In order to directly evaluate the
capacity of the wild promoter sequences of the A and B subunits to drive protein expression in mammalian cells, GFP was
cloned under eukaryotic-like putative promoter sequences. GFP expression was observed in 293T cells transfected with
these constructions. These results show a novel and alternative way to synthesize Stx2 that could contribute to the global
understanding of EHEC infections with immediate impact on the development of treatments or vaccines against HUS.
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Introduction
Shiga toxins (Stx) are the main virulence factors in enterohe-
morrhagic Escherichia coli (EHEC) infections, causing diarrhea,
hemorrhagic colitis, and hemolytic uremic syndrome (HUS). The
infection is associated with the ingestion of contaminated meat or
vegetables but is also transmitted by water or even person-to-
person contact [1–3]. Sporadic or massive outbreaks have been
reported in several developing countries. In Argentina, HUS is
endemic and represents a serious public health problem with high
morbidity and mortality rates [4,5].
Shiga toxin is a member of the AB5 family of bacterial toxins.
The A subunit (StxA) possesses N-glycosidase activity against 28S
rRNA of 60S ribosomes in the cytosol, resulting in inhibition of
protein synthesis in eukaryotic cells. The five B subunits (StxB)
form a pentamer that binds to globotriaosyl ceramide receptors
(Gb3) on the cell membrane [6]. Stx-producing E. coli (STEC)
express two types of Stx proteins (Stx1 and Stx2) and their
variants, being Stx2 more virulent and epidemiologically more
relevant than Stx1.
In most of the STEC strains identified, the toxin genes, stxAB,
are located in the genomes of prophages that resemble the
coliphage lambda [7]. The lytic phase, which is induced under
stress conditions, leads to an enhancement of Stx2 production and
release [8–10]. In this stage, the viral progeny is able to infect
other bacteria present in the gut [11,12]. It has been demonstrated
that Stx phages can survive even after host death. Moreover,
under convenient circumstances, the phage may transduce in vivo
and in vitro other bacteria [13]. In fact, Shiga toxin-converting
bacteriophages are able to infect and lysogenize laboratory strains
of E. coli as well as E. coli strains derived from the human intestine
[14]. The resulting lysogenic strains are able to produce toxins and
infectious phage particles, facilitating the spread of toxin genes
among E. coli strains and other Enterobacteriaceae [14].
On the other hand, different lines of evidence have shown that
bacteriophage lambda is able to transduce mammalian cells, and
that bacteriophage lambda vectors containing a mammalian gene
expression cassette are able to express encoded genes in
mammalian target cells in vitro [15–17] and in vivo [18,19]. The
ability of lambda phage particles to transduce mammalian cells
in vivo depends on the phagocytic and nonphagocytic uptake of the
phage, possibly including macropinocytosis, and is increased
through an Fc receptor-mediated antibody-dependent mechanism
[20].
The interaction between EHEC and macrophages has been
reported and it has been shown that phagocytosis of EHEC by
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murine macrophages causes actin rearrangements surrounding the
phagosome. Intracellularly produced Stx has been shown to be
responsible for these effects [21]. In the same line of evidence, a
correlation between the E. coli O157:H7 phagocytosis by THP-1
human macrophages and the presence of Stx within the cells has
been recently described. In addition, stxA and stxB transcription in
infected macrophages and upregulation of SOS response genes
(such as recA, recC, and recN) occur simultaneously [22]. We
analyzed the hypothesis that, independently of the mechanism
through which bacterial stx genes are delivered into mammalian
cells during EHEC intestinal infection, eukaryotic cells are able to
transcribe a functionally active Stx-like protein. In a previous
report, BHK cells transfected with a DNA vaccine carrying the
wild-type promoters of Stx2 were able to express both subunits. B
subunit expression probably reflected the presence of eukaryotic
putative promoter-like sequences located upstream of it [23].
Therefore, the aim of this study was to evaluate the ability of the
eukaryotic machinery to recognize genetic sequences as stx2
promoters, to transcribe a Stx2-like protein and produce the
functionally active toxin. For this purpose, we designed plasmid
constructions using green fluorescent protein (GFP) under putative
promoter-like sequences located upstream of the open reading
frames (ORFs) of stxA and stxB, and tested them for GFP
expression. In addition, we transfected two eukaryotic cell lines
with different sensitivity profiles to Stx2, Vero and BHK cells, with
a plasmid construction carrying the stx2 gene under its own
promoter. In both cells we confirmed the Stx2-specific cytotoxic
effect.
These results suggest the existence of a new pathway in Stx2
production. In the context of the inflammatory response that takes
place in the gut, the phagocytic cells (macrophages and
neutrophils) could uptake stx genes, produce the active toxin and
release it into the bloodstream. Although immune cells may
produce low doses of Stx2, they may play an important role in the
EHEC pathogenesis and in the global course of infection. In order
to develop an efficient procedure for the treatment of EHEC
infections, it is necessary to understand the mechanisms involved
in the expression of the genes encoding Shiga toxins. In this
regard, the present study may open new avenues for the treatment
and prevention of HUS.
Results
In silico Analysis
We analyzed the whole sequence of stx2 including the promoter
region by means of several softwares to find putative eukaryotic
promoter sequences. Seven putative eukaryotic promoter-like
sequences were computationally detected (Figure 1). Based on
their position, pr1 and pr7 putative promoter sequences were
additionally analyzed to find transcription factor binding sites. The
pr1 sequence contains five eukaryotic transcription factor binding
sites, MEB-1, GATA-1, TATA box, Sp1 and NF-1, whereas the
pr7 sequence contains three eukaryotic transcription factors
binding sites, TEF, TATA box and HNF-3B. The protein factors
that bind to these sequences could act together with RNA
polymerase to initiate a transcriptional process [24].
Pr1 and Pr7 Sequences are Recognized by Eukaryotic
Cells
The pr1 and pr7 sequences were selected to further analyze the
promoter activity in the eukaryotic environment. The pr1-eGFP
and pr7-eGFP reporter plasmids were constructed to test whether
the prokaryotic sequences could drive the transcription of the gfp
gene (Figure 2). These plasmids were used in circular and
linearized forms and pEGFP-N3 and Dpr-eGFP were used as
positive and negative controls, respectively.
293T cells were transfected with the constructions and GFP
expression was analyzed by fluorescence microscopy. We observed
GFP expression when cells were transfected with pr1-eGFP
(Figure 3, panel B) or pr7-eGFP (Figure 3, panel C). In contrast,
no fluorescence was detected when 293T cells were transfected
with the Dpr-eGFP plasmid (Figure 3, panel A). In addition, GFP
expression was observed when cells were transfected with the
linearized forms of pr1-eGFP or pr7-eGFP (Figure 4 panels B and
C respectively). These results demonstrate that pr1 and pr7 are the
sequences used by mammalian to drive GFP expression.
To evaluate the relevance of TATA box present at pr1 and pr7
sequence, a mutational assay was done. The six nucleotides of the
TATA box core were replaced by a BamHI restriction site giving
pr1DTATA-eGFP or pr7DTATA-eGFP [Figure 2]. GFP expres-
sion was not observed when 293T cells were transfected with
pr1DTATA-eGFP or pr7DTATA-eGFP (Figure S1, panels A and
B respectively), suggesting that this sequence plays a critical role in
the promoter activity of the putative promoters.
Eukaryotic Cells Transfected with pStx2 are Able to
Express Stx2 Protein
To evaluate the expression of the Stx2 protein in the eukaryotic
environment, Vero cells were transfected with pStx2, and
intracytoplasmic Stx2 was revealed after 48 hours by an indirect
immunofluorescence assay using a polyclonal anti-Stx2 antibody
(Figure 5). Cells incubated with Stx2 (Figure 5, C/D) or cells
transfected with pStx2 (Figure 5, E/F) shown similar specific
staining. No fluorescence was detected in Vero cells without
treatment (Figure 5A) or transfected with the empty plasmid
(Figure 5B).
Stx2 Expressed by Eukaryotic Cells is Biologically Active
We then evaluated the Stx2-specific cytotoxicity after pStx2-
transfection of Vero cells, as a representative Stx2-susceptible cell
line. Cells incubated with purified Stx2 and cells transfected with
the empty plasmid were used as positive and negative controls,
respectively. Non treated cells were also analyzed.
After 48 hours, Vero cells transfected with pStx2 (Figure 6C)
showed a similar cytotoxicity to that of cells incubated with 1
CD50 of purified Stx2 (Figure 6D). No cytotoxic effects were
observed in non-treated Vero cells (Figure 6A) or transfected with
control plasmid (Figure 6B).
In order to further analyze the cytotoxicity induced by pStx2,
non-treated (naı̈ve) Vero cells were incubated for 48 hours with
supernatants or cellular extracts derived from Vero cells
transfected with pStx2, or with the empty plasmid as control.
Both the supernatants and cellular extracts obtained from pStx2-
transfected cells showed cytotoxic effect on naı̈ve Vero cells
(Figure 7). No cytotoxicity was observed in non-treated Vero cells
or Vero cells incubated with supernatants or extracts from Vero
cells transfected with the control plasmid. Significant neutraliza-
tion of the cytotoxic activity was observed when supernatants or
cellular extracts were incubated with mouse polyclonal anti-Stx2
antibodies, confirming that the cytotoxicity was specifically
induced by Stx2 (Figure 7). To rule out cryptic promoter activity
in the pGEMT backbone, pStx2 was digested with EcoRI and the
fragment containing stx2 coding sequence alone was gel purified
and used to transfect Vero cells. After 48 hours, Vero cells
transfected with the linear DNA still showed cytotoxicity.
However, quantification of cytotoxicity revealed that it was two-
fold less cytotoxic than its counterpart pStx2 (data not shown).
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Figure 1. In silico analysis of the stx2 sequence. A. Seven regions (pr1-7) with high score for putative eukaryotic promoter sequences were
found. The putative transcription start site (TSS, +1) detected with promoter prediction server is highlighted in gray B. The pr1-pr7 regions are
indicated with dark gray boxes over the stx2 gene. Putative mammalian transcription factor binding sites are indicated on the corresponding
sequences of the pr1 and pr7 regions.
doi:10.1371/journal.pone.0057128.g001
Figure 2. Recombinant plasmid constructs. pStx2 is the pGEM-T plasmid with the stx2 locus cloned in the same direction that lacZ promoter.
pr1-eGFP and pr7-eGFP are reporter plasmids with the region pr1 or pr7 driving eGFP expression, and Dpr-eGFP is a construction lacking the wild
CMV promoter and was used as negative control. Linear pr1-eGFP and pr7-eGFP were obtained after digestion with PciI. In pr1DTATA-eGFP and
pr7DTATA-eGFP TATA Box sequence has been replaced by BamHI restriction site. Stx2 linear DNA was obtained after digestion with EcoRI.
doi:10.1371/journal.pone.0057128.g002
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Stx2 Expressed by BHK Cells Induces Morphological
Changes
BHK cells transfected with pStx2 showed morphological
alterations and changes in their growth as evaluated by optical
microscopy. BHK cells transfected with pStx2 increased their
intracellular spaces and the cells became rounder and smaller.
However, cells transfected with the control plasmid or non-treated
cells did not shown morphological changes. To further analyze
pStx2 effects on actin and nucleic acids on BHK cells, fluorescence
assays were performed using phalloidin-TRITC and DAPI,
respectively. Cytoskeleton changes were observed 48 hours after
transfection. pStx2-transfected BHK cells showed filopodia-like
and lamellipodia-like structures (Figure 8D), as Takenouchi and
collaborators previously reported in ACHN cells treated with
Stx1B [25].
Figure 3. GFP activity driven by the pr1 or pr7 regions. 293 T cells were transfected with plasmids pr1-eGFP, pr7-eGFP or Dpr-eGFP, incubated
for 48 h and analyzed by fluorescence microscopy using the Nikon Eclipse TE2000 microscope equipped with a CCD camera, with 1000X
magnification. Green fluorescence photos were taken with 400 ms of exposure and 3.2 of gain. Numbers 1, 2, 3, 4 correspond to images visualized
with white light, green filter, merge between DAPI and green filter and merge between white light and green filter, respectively. A. Cells transfected
with the Dpr-eGFP plasmid. B. Cells transfected with pr1-eGFP. C. Cells transfected with pr7-eGFP.
doi:10.1371/journal.pone.0057128.g003
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We did not observe these effects in BHK cells without treatment
(Figure 8A) or in those transfected with the control plasmid
(Figure 8B). No effect was observed in BHK cells incubated with
Stx2 (Figure 8C).
Transduction of THP-1 Cells Differentiated to
Macrophages by Bacteriophage 933W
To analyze the hypothesis that 933W bacteriophage is able to
transduce mammalian cells in vivo, THP-1 cells PMA-differen-
tiated to macrophages were incubated with purified 933W
bacteriophage in which stx2 gene was replaced by gfp sequence
(wDTOX-GFP) [14]. We observed GFP expression when
macrophages were incubated with wDTOX-GFP (Figure 9,
panel A). No fluorescence was observed in non-treated
macrophages (Figure 9, panel B).
Figure 4. GFP activity driven by linear reporter plasmid. 293 T cells were transfected with pr1-eGFP or pr7-eGFP linearized with Pcil restriction
enzyme. After 48 h, cells were analyzed by fluorescence microscopy using Nikon Eclipse TE2000 microscope equipped with a CCD camera, using
1000X magnification. Green fluorescence photos were taken with 400 ms of exposure and 3.2 of gain. Numbers 1, 2, 3, 4 correspond to images
visualized with white light, green filter, merge between DAPI and green filter and merge between white light and green filter, respectively. A. 293 T
cells transfected with the Dpr-eGFP plasmid. B. Cells transfected with linear pr1-eGFP. C. Cells transfected with linear pr7-eGFP.
doi:10.1371/journal.pone.0057128.g004
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Figure 5. Immunofluorescence assay of Vero cells incubated with Stx2. Cells were incubated with purified Stx2 (100 CD50) or transfected
with the pStx2 plasmid and stained with propidium iodide. Presence of Stx2 was detected with polyclonal anti-Stx2 serum and FITC-conjugated goat
anti-mouse antibody, and analyzed by confocal microscopy. Original magnification 600X. A: Non-treated Vero cells. B: Cells transfected with the
pGEM-T vector alone. C: Cells incubated with purified Stx2. D: Digital zoom (3.5X) of picture C. E: Cells transfected with pStx2. F: Digital zoom (3.5X)
of picture E.
doi:10.1371/journal.pone.0057128.g005
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Discussion
The main finding of the present article was the demonstration of
the existence of putative eukaryotic promoter-like sequences
located upstream of the genes encoding for the Stx2 A and B
subunits. Moreover, the eukaryotic machinery was able to
recognize these sequences and to initiate the transcription and
translation leading to the synthesis of functional active Stx2-like
protein.
Production of Shiga toxins is generally associated with prophage
induction, which depends, among other factors, on the location of
the integration site in the bacterial genome, which in turn depends
on the phage type and bacterial host. In addition, it depends on
the activation of the bacterial RecA protein, which causes
autocleavage of the cI repressor encoded by the phage [26,27].
This mechanism allows the transcription from phage promoters, in
addition to the pR’ promoter, which controls the transcription of
the stxA and stxB genes. In this context, factors that damage DNA
or inhibit replication of the bacterial genome can activate the SOS
system, and lead to prophage induction and production of large
quantities of toxins.
Many of the prophages found in E. coli O157 strains are
lambdoid phages, two of which, Sp15 and Sp5, carry the stx1 and
stx2 genes, respectively [28]. In the prototype of the lambdoid
family, lambda phage, Int and Xis proteins are needed to produce
an efficient excision of genomic DNA from the bacterial genome
both in vivo and in vitro [29].
It is known that prophage release/replication and toxin
production are correlated. One of the physiological extracellular
signals that induce prophage activation is the presence of hydrogen
peroxide released from human neutrophils after lysogenic bacteria
uptake [30,28]. The excision process triggers the replication
cascade and the generation of phage progeny. Furthermore,
within the phagocytic vesicles, bacteria are under stress and the
lytic cycle is activated. Some excised DNA molecules can be
released into the cytoplasm from the phagocytic vesicle or
phagolysosome, and then be incorporated to the nucleus.
Otherwise, the free phage could transduce eukaryotic cells and
the DNA phage could be transported to the nucleus [19].
On the other hand, several reports have demonstrated that
bacteria could transfer plasmid-encoded genes to both bacterial
and eukaryotic cells. In particular, gene transfer from Salmonella to
mammalian macrophages and dendritic cells has been observed
[31–33]. Likewise, when the lytic cycle of phages is activated in the
phagolysosome after bacterial phagocytosis by macrophages,
transfer of stx genes may occur [30,34]. Thus, intracellularly
released DNA phages could use either one or both mechanisms of
gene delivery, via the viral particle or by the naked DNA phage.
Both of these mechanisms might transfer the stx gene to the
cellular nuclei where it can be transcribed. In either situation, the
eukaryotic transcriptional machinery could recognize the DNA
Figure 6. Cytotoxicity on Vero Cells. Vero cells were incubated with purified Stx2 (1 CD50) or transfected with pStx2 plasmid. After 48 h, cells
were stained with Crystal Violet and analyzed by optical microscopy. Representative pictures using 200X original magnification are shown. A. Non-
treated Vero cells. B. Cells transfected with the pGEM-T plasmid. C. Cells transfected with the pStx2 plasmid. D. Cells incubated with purified Stx2.
doi:10.1371/journal.pone.0057128.g006
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Figure 7. Neutralization of the Stx2 cytotoxic activity. Vero cells were incubated with a 1:1600 dilution of cellular extracts (Panel A) or a 1:400
dilution of culture supernatants (Panel B) derived from Vero cells transfected with pGEM-T (pGEM-T) or pStx2 (pStx2). As positive and negative
Shiga-Toxin Promoter Sequences in Eukaryotic Cells
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sequences encoding Stx2 toxins. Binding motifs for eukaryotic
transcription factors detected in the sequence of stx2 and described
in this article support this hypothesis.
In the present work, we explored the ability of mammalian cells
carrying stx2 coding DNA to produce Stx2, constituting an
alternative Stx2 source during the course of the EHEC infection.
In a previous report, we have shown that the B subunit of Stx2
is expressed in the eukaryotic environment without the need of an
additional eukaryotic promoter, involving probably its own
upstream sequences [23].
In mammalian cells, transcriptional regulation requires the
cooperation of multiple factors and specific sequences (cis-
regulatory elements), including promoters, enhancers and silenc-
ers. The structure of the eukaryotic core promoter contains the
TATA box, BRE (TFIIB recognition element), MTE (Motif Ten
Element), DPE (Downstream Promoter Element), Inr (Initiator)
and DCE (Downstream Core element) sequences, among others.
Very often, mammalian core promoters contain CG-rich sequenc-
es called CpG islands or a mix of different motifs. The Sp1 binding
site is often found in this type of core promoters [35].
The initiation of transcription in the eukaryotic environment
can occur over a single start site (focused core promoter) or over
distinct start sites into a short region (dispersed core promoter),
depending on which binding motifs are present. Focused core
promoters are mainly related to the TATA box, Inr and DPE
motifs, whereas dispersed core promoters are related to CpG
island motifs [36–39].
In silico analyses of the stx2 gene suggest the presence of different
typical core promoter regulatory sequences. We focused only in
the putative promoter sequences pr1 and pr7 that are located
upstream of the stx2A and stx2B ORFs respectively (Figure 1),
because if functional, they allow the synthesis of the complete
sequences of A and B subunits respectively. A detailed bioinfor-
matic analysis using transcription factor binding site databases and
different servers led to the detection of several eukaryotic
transcription factor binding motifs. In the pr1 putative promoter
sequence, we detected five binding sites: MEB-1, GATA-1 and
TATA box (partially overlapped with each other), and Sp1 and
NF-1 (overlapped with TSS) (Figure 1). In the pr7 putative
promoter sequence, we detected three binding sites: TEF and
TATA box (partially overlapped), and HNF-3B. Based on this
analysis, the pr1 and pr7 sequences could be acting as putative
sequences in a eukaryotic context with potential promoter activity
for the A and B subunits, respectively. Monolayers of 293T cells
transfected with pr1-eGFP and pr7-eGFP showed GFP expression,
demonstrating that eukaryotic cells should recognize both
sequences as functional promoters. Although TATA box is not
the only one eukaryotic transcription factor binding sites found, it
controls, Vero cells were incubated with 1 CD50 of Stx2 (Stx2) or in medium (Vero cells), respectively. To evaluate the specificity of the cytotoxicity,
cytotoxic samples were pre-incubated with mouse polyclonal anti-Stx2 antibodies (pStx2+Ab; Stx2+Ab). After 48 h, cells were stained with Crystal
Violet and OD595 was measured as detailed in Materials and Methods. One-way ANOVA (Tukey’s Multiple Comparison Test) was used to determine
statistical significance between different samples.*P,0.05. **P,0.01. ***P,0.001.
doi:10.1371/journal.pone.0057128.g007
Figure 8. Cytotoxicity on BHK cells. BHK cells were incubated with purified Stx2 (1 CD50) or transfected with the pStx2 plasmid. After 48 h, cells
were stained with DAPI and phalloidin-TRITC and analyzed by fluorescence microscopy. Original magnification 600X. A. Non-treated BHK cells. B.
Cells transfected with pGEM-T. C. Cells incubated with purified Stx2. D. Cells transfected with the pStx2 plasmid.
doi:10.1371/journal.pone.0057128.g008
Shiga-Toxin Promoter Sequences in Eukaryotic Cells
PLOS ONE | www.plosone.org 9 February 2013 | Volume 8 | Issue 2 | e57128
Shiga-Toxin Promoter Sequences in Eukaryotic Cells
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e57128
is known that TBP (TATA binding protein) along with other TBP-
associated factors, make up the transcription Factor II D (TFIID),
a general transcription factor that in turn makes up part of the
RNA polymerase II pre-initiation complex [40]. Because TBP is
one of the few proteins in the pre-initiation complex that binds
DNA in a sequence-specific manner, it helps to position RNA
polymerase II over the transcription start site of the gene. GFP
expression was not observed when we transfected 293T cells with
pr1DTATA-eGFP or pr7DTATA-eGFP, suggesting that this
sequence plays a critical role in the promoter activity of the
putative promoters. However, these results are not enough to
attribute to TATA box the total role in driving Stx2 expression.
Further studies will be necessary to fully define the role of the other
mammalian transcription factor binding sites present in the Stx2
sequence.
Moreover, Vero cells transfected with pStx2 produced an active
Stx2-like protein that was specifically detected or neutralized by
anti-Stx2 antibodies. In addition, the linear stx2 sequence was still
able to induce cytotoxicity in Vero cells, discarding the presence of
a cryptic promoter activity in the pGEMT backbone. The less
cytotoxicity observed comparing the linear stx2 sequence with
pStx2 is probably due to the lower efficiency of transfection
between linear DNA sequences and supercoiled plasmid.
It is known that Stx2 binds to its specific receptor on
mammalian cells, the globotriaosyl ceramide (Gb3), to exert its
cytotoxic effects. However, Gb3 expression is insufficient to confer
sensitivity to Stx2, implying that other key factors, such as toxin-
receptor internalization or intracellular degradation, are important
for its effect [41]. The data published so far suggest that Stx2
toxins need to traverse the cell membrane to exert their effects on
protein synthesis.
The toxin binds to Gb3 receptors and it is internalized through
clathrin-dependent and -independent mechanisms. Once inter-
nalized, the toxin can follow one of several routes. The fatty acid
chain composition in the receptor, rather than the toxin itself,
contains the trafficking signal necessary to translocate the toxin
from the membrane to the cytosol. Along this intracellular way,
the A and B subunits of Stx2 disassociate, unfold, and the cleavage
of the A subunit into the A1 and A2 subunits triggers its enzymatic
activity [42,43].
Vero and BHK cells transfected with pStx2 showed different
cytotoxic profiles probably due to their different toxin sensitivity.
Vero cells transfected with pStx2 showed high cytotoxicity, similar
to that observed when cells were incubated with exogenous
recombinant Stx2.
Moreover, supernatants and cytoplasmic fractions from Vero
cells transfected with pStx2 were able to induce a specific cytotoxic
effect when they were added to naı̈ve Vero cells. These results
suggest that Stx2 is synthesized and released by Vero cells, acting
in autocrine and paracrine ways in other non-transfected Vero
cells, probably through the interaction with the Gb3 receptor
present in the membrane. Indeed, it is possible that different and
alternative mechanisms were acting simultaneously.
On the other hand, BHK cells transfected with pStx2 showed
no significant lysis, but a clear Stx2 cytotoxic effect was observed
on the actin cytoskeleton. These results probably reflected the low
sensitivity of BHK cells to exogenous Stx2, due to the low Gb3
expression and/or their different fatty acid composition, but
showed the Stx2 effect when it is produced intracellularly.
Similarly, Nakagawa et al. [44] also reported cytotoxic effects in
NIH3T3 and HeLa cells transfected with the Stx1A or Stx1B
subunits, both cloned into pcDNA3.1 vectors. However, they
observed no morphological changes or DNA fragmentation upon
the addition of recombinant Stx1B protein (monomeric form) to
NIH3T3 and HeLa cell cultures. The cells transfected with the
stx1B gene became apoptotic with DNA fragmentation, whereas
the cells transfected with the stx1A gene were found to be necrotic
but without signs of DNA fragmentation.
Moreover, actin morphological changes in macrophages infect-
ed with Stx-producing Escherichia coli O157:H7 have also been
described [45]. Interestingly, in this report the authors suggested
that the Stx released by the bacteria directly into the cytoplasm is
responsible for the actin rearrangement in macrophages.
In conclusion, the capacity of mammalian cells to transcribe and
translate stx2 genes could have important pathological implica-
tions. First, it could contribute to the entry of Shiga toxins into the
bloodstream. Secondly, the large numbers of inflammatory cells
(macrophages and/or neutrophils) present during the infection
process may release biologically active Stx2 close to target
endothelial cells. Additionally, as preliminar data, we observed
that purified wDTOX-GFP was able to transduce the differenti-
ated macrophagic THP-1 human cell line supporting our
hypothesis that 933W bacteriophage could be able to transduce
mammalian cells in vivo.
Thus, this alternative mechanism would not require a high
blood concentration of Stx2 to be effective. In this regard, it has
been recently demonstrated that a concentration as low as 10 fM
of Stx2 is able to induce ribosome damage and to modulate
selected cell signaling pathways that change cellular functions [46].
Understanding host-pathogen interactions is fundamental to
develop vaccines and new specific therapeutic agents.
Materials and Methods
In silico Analysis of the stx2 Sequence
In order to detect eukaryotic transcription factor binding sites in
the stx2 sequence, the putative promoter was analyzed with Neural
Network Promoter Prediction v2.2 (http://www.fruitfly.org/
seq_tools/promoter.html), which contains standardized data sets
of human and Drosophila melanogaster genes. The putative promoters
pr1 and pr7 were analyzed with the following server: AliBaba2.1
(http://www.gene-regulation.com/pub/programs/Alibaba2). The
analysis was performed using the binding sites collected in
TRANSFAC 4.0 database and default parameters (Pairsim to
known sites: 50; Mat. width in bp: 10; minimum number of sites:
4; Minimum matrix conservation: 75%; Similarity sequence to
matrix: 1%; Factor class level: 4).
Plasmid Constructions
pStx2. The stx2 complete sequence was amplified by PCR
from total DNA from E. coli O157:H7 C600 (933W), using the
primers Stx2Fw (59-GAATTCATTATGCGTTGTTAG-39) and
Stx2R (59-GAATTCTCAGTCATTATTAAACTG-39), both
containing an EcoRI restriction site [23]. The resulting fragment
(1413 bp) was cloned in a pGEMT easy vector (PROMEGA Inc),
Figure 9. Transduction of THP-1 cells differentiated to macrophages by bacteriophage 933W. THP-1 cells PMA-differentiated to
macrophages were transduced with wDTOX-GFP. After 3 h, cells were analyzed by confocal microscopy, using 600X magnification. Green
fluorescence photos were taken with 400 ms of exposure and 1 of gain. Numbers 1, 2, 3, 4 correspond to images visualized with white light, red filter,
green filter and merge between green and red filter, respectively. A. Cells transduced with wDTOX-GFP. B. Non-treated cells.
doi:10.1371/journal.pone.0057128.g009
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generating the plasmid pStx2. This plasmid was replicated in E.
coli DH5a competent cells.
As an additional control pStx2 was digested using EcoRI and
the stx2 complete sequence was gel purified, and used to transfect
Vero cells.
pr1-eGFP. The pr1 motif localized immediately upstream to
the stx2A open read frame (ORF) was amplified by PCR from the
pStx2 construction, using the primers Stx2Fw1 (59-GCTCTAGA-
CATGTCATATTTATTTACCAGGCTCGC-39) and Stx2R1
(59-CCCCAAGCTTATACAGGTGTTCCTTTTGGC-39), con-
taining restriction sites PciI-XbaI and HindIII respectively. PCR
fragment was digested with PciI and HindIII. The plasmid
pEGFP-N3 was digested with the same enzyme in order to
eliminate the wild CMV promoter (Clontech Laboratories, CA,
USA). PCR fragment and the plasmid, digested, were ligated and
transformed in E. coli DH5a competent cells. The construction
was digested with PciI restriction enzyme to obtain the linear
sequence. All restriction enzymes used were purchased from
Fermentas International Inc.
pr7-eGFP. The pr7 motif localized immediately upstream to
the stx2B ORF was amplified by PCR from the pStx2 construction
using the primers Stx2Fw7 (59-GCTCTAGACATGTTA-
CAGCTGCAGCGTTTCTGAAC-39) and Stx2R7 (59-
CCCCAAGCTTTCTTCTTCATGCTTAACTCCT-39), con-
taining restriction sites PciI-XbaI and HindIII respectively. PCR
fragment was digested with PciI and HindIII. The plasmid
pEGFP-N3 was digested with the same enzyme in order to
eliminate the wild CMV promoter (Clontech Laboratories, CA,
USA). PCR fragment and the plasmid, digested, were ligated and
transformed in E. coli DH5a competent cells. The construction
was digested with the PciI restriction enzyme to obtain the linear
sequence.
Dpr-eGFP. The plasmid pEGFP-N3 was digested with PciI
and HindIII, filled in with the Klenow fragment (PROMEGA
Inc.) and re-ligated as negative control.
pr1DTATA-eGFP and pr7DTATA-eGFP. Complementary
oligonucleotides (Macrogen Inc., Seoul, Republic of Korea) in
which TATA box sequence was replaced by BamHI restriction





GCCCGCAAAAGCGAGCCTGGTAA-39; R7-TATAf 59- CA-
TGTTACAGCTGCAGCGTTTCTGAACAGAAAGTCACAG-
TGGATCCATACAACGGGTAAATAAAGGAGTTAAGCAT-
GAAGAAGAA-39, R7-TATAr 59- AGCTTTCTTCTTCATG-
CTTAACTCCTTTATTTACCCGTTGTATGGATCCACTG-
TGACTTTCTGTTCAGAAACGCTGCAGCTGTAA-39). pr1-
eGFP and pr7-eGFP were digested with PciI and HindIII and
ligated to the pr1DTATA or pr7DTATA fragment obtaining
pr1DTATA-eGFP and pr7DTATA-eGFP respectively.
Stx2 Preparation
The toxin was purified as reported previously [23]. Briefly, E.
coli JM109 transformed with plasmid pGEMT-Stx2 was used to
express Stx2 protein. Bacteria were grown in Luria broth
overnight in the presence of ampicillin (50 mg/ml). Cells were
broken by ultrasonic treatment, centrifuged and the supernatant
was treated with ammonium sulfate at 70% saturation. The
precipitate was collected by centrifugation, resuspended in 3 ml of
phosphate-buffered saline (PBS), and dialyzed with the same buffer
for 24 h. Total protein concentration was determined by standard
methods.
Stx2 concentration was determined with RidascreenH Vero-
toxin kit (R-biopharm AG, Darmstadt, Germany). We calculated
that 1CD50 (cytotoxic dose that kills 50% of Vero cells) of Stx2 is
equivalent to 670 pg of Stx2.
Anti-Stx2 Polyclonal Antibodies
Balb/c mice were immunized with Stx2 toxoid. Stx2 toxoid was
prepared by formalin treatment of Stx2 [47]. Briefly, 100 mg of
Stx2 (Phoenix Lab, Tufts University, Boston, MA) was incubated
overnight in 2% formalin and then dialyzed extensively against
PBS. Mice were immunized with 5 mg of Stx2 toxoid emulsified in
Freund’s complete (initial immunization) or incomplete (subse-
quent immunizations) adjuvant. Mice received Stx2 toxoid
biweekly intervals a minimum of three times.
In vitro Evaluation of Shiga Toxin Production
Vero cells transfected with pStx2 or pGEMT were grown for
48 h. The supernatants were collected and the cells were harvested
with 800 ml RPMI and lysed by four freeze-thaw cycles. Serial
two-fold dilutions of supernatants or lysates were tested for
cytotoxic activity on Vero cells as previously described [48].
Briefly, Vero cells were grown in complete medium on microtiter
plates. Aliquots (150 ml) of serial two-fold dilutions of lysates and
supernatants were added to each well containing 104 Vero cells.
Cells were incubated for 48 h at 37uC in 5% CO2. Cells were
washed, stained with crystal violet dye, and read on a Microwell
System reader 230S (Organon, Teknika, OR) with a 570 nm filter.
The specificity of cytotoxicity was evaluated in parallel, by pre-
incubating each sample with mouse anti-Stx2 polyclonal antibody
(dilution 1/400) for 1 h at 37uC and for 1 h at 4uC. A positive
control with purified Stx2 (1CD50) was carried out.
Transfection Assays
BHK-21 (Syrian hamster kidney fibroblasts from the American
Type Culture Collection) and Vero cells (kidney epithelial cells of
the African Green Monkey) were grown in RPMI 1640 medium
(EMEVE Microvet SRL Laboratories, Argentina), supplemented
with 10% fetal bovine serum (Natocor, Argentina), 100 U/ml
penicillin G sodium, 100 mg/ml streptomycin sulphate, and
0.25 mg/ml fungizone (GIBCO, Grand Island, NY, USA)
(complete medium) to 46105 cells/well in six-well culture plates
(GBO, Germany), at 37uC in 5% CO2. Cells were washed twice
with serum-free medium and transfected with Polyfect reagent
(QIAGEN Inc, CA, USA). Briefly, 2.5 mg of plasmid pStx2, linear
stx2 or pGEMT (PROMEGA Inc.) religated vector were mixed
with 15 ml of Polyfect reagent following the manufacturer’s
instructions. After 10 minutes, the cells were incubated with the
transfection mix (DNA-polyfect) for 48 h using complete medium
at 37uC in 5% CO2. The pStx2-transfected cells were analyzed by
cytotoxic assay, or fixed for immunofluorescence analysis.
293T cells (human embryonic kidney cells) were transfected
with supercoiled or linear peGFP constructions (pr1-eGFP,
pr1DTATA-eGFP, pr7-eGFP, pr7DTATA-eGFP and Dpr-eGFP)
as described above. Cells were analyzed by fluorescence micros-
copy.
Analysis of Cytoskeletal Actin
BHK cells were grown on cover slips and transfected with pStx2
as previously described. After 48 hours, cells on cover slips were
washed with PBS and fixed with PBS containing 1% p-
formaldehyde (PFA) for 15 minutes at room temperature. Cells
were washed three times with PBS for 5 minutes, permeabilized
with PBS containing 0,25% Triton X100 for 15 minutes at room
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temperature, and washed again three times with PBS for 5
minutes. Cells were stained with phalloidin-TRITC (Sigma-
Aldrich, St. Louis, MO, USA) and DAPI (Molecular Probes-
Invitrogen, CA, USA) according to the manufacturer’s specifica-
tions. The samples were analyzed by fluorescence microscopy in a
Nikon Eclipse TE2000 (NIS-Elements imaging software) equipped
with a CCD camera.
Immunofluorescence Assays
Vero cells were grown on cover slips, transfected with pStx2 or
pGEMT vector and incubated for 48 h. As positive control, cells
were incubated with purified Stx2 (100CD50) for 2 h at 37uC.
Cells were washed with PBS, fixed with PBS containing 1% PFA
for 15 minutes at room temperature and washed three times with
PBS. Cells were permeabilized with 0.25% Triton X100 in PBS
for 15 minutes at room temperature, washed again three times
with PBS and incubated with block solution (Triton X100 0.25%,
BSA 4%, PBS 1X) for 90 minutes at 37uC. Then, cells were
incubated with mouse anti-Stx2 polyclonal antibody diluted 1/100
in block solution for 90 minutes at 4uC, washed five times with
PBS and incubated with goat anti-mouse IgG2FITC antibody
(dilution 1/2000) for 45 minutes at 4uC (Jackson ImmunoRe-
search Laboratories Inc., PA, USA). Finally, the samples were
washed five times with PBS, stained with propidium iodide (PI)
(Sigma-Aldrich) (5 mg/ml) and analyzed with FluoViewTM
FV1000 Confocal Microscope (Olympus). Excitation wavelengths
were 488 nm for FITC and 543 nm for PI and a sequential mode
was used. The numerical aperture was 1.42 on a 60X oil objective.
In vitro Evaluation of the Ability of Bacteriophage 933W
to Transduce THP-1 Differentiated Cells
C600: DTOX-GFP was generously provided by Dr Alison
Weiss [14]. It is a non-pathogenic phage resulting from purified
933W bacteriophage in which stx2 gene was replaced by gfp
sequence. THP-1 cells were differentiated to macrophages by
incubation with phorbol-12-myristate-13-acetate (PMA) during
48 h. Phages at a multiplicity of infection (M.O.I) equal to 1 were
added to macrophages. Transduction of macrophages was
enhanced by centrifugation at 1000 6 g for 10 min at room
temperature. After 10 min at 37uC, medium containing phage was
removed and cells were washed twice with PBS and then
incubated in complete medium. After 3 hours post infection, the
cells were examined by FluoViewTM FV1000 Confocal Micro-
scope (Olympus).
Statistical Analysis
The significance of the difference between treatments was
analyzed using (ANOVA with Tukey’s post-test) with Prism 5.0
software (GraphPad Software), and the p value is indicated by
asterisks in the figures.
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Supporting Information
Figure S1 GFP activity driven by pr1DTATA-eGFP and
pr7DTATA-eGFP. 293 T cells were transfected with
pr1DTATA-eGFP or pr7DTATA-eGFP. After 48 h, cells were
analyzed by fluorescence microscopy using Nikon Eclipse TE2000
microscope equipped with a CCD camera, using 400X magnifi-
cation. Green fluorescence photos were taken with 600 ms of
exposure and 1 of gain. Numbers 1, 2, 3, 4 correspond to images
visualized with white light, green filter, DAPI, merge between
white light, green filter and DAPI respectively. A. Cells transfected
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